Peters, de Bruin, and Crutzen (2013) concluded (1) that past research syntheses have often neglected the finer points of behavioural theories, making for dubious conclusions and ineffective health promotion efforts and (2) offered an iterative protocol for evidence base accumulation (IPEBA) as a way to blend work from theories, experiments, and metaanalyses of experiments. In the spirit of science, we heartily agree that when it is possible and feasible to improve methods one should do so, especially when the outcomes can improve public health. That said, we believe that instantiating IPEBA needs to account for several stubborn particulars of an all-too-often messy research reality:
Pressure to do something, anything, to help. Health promotion interventions are
often-and perhaps even usually-confounded, and use "everything except the kitchen sink" as intervention content. For some targeted behaviours, life itself is often at stake for the targeted population-such as HIV prevention at times or in places with no available drug therapy. These trials may not be the clean tests of theories that IPEBA envisions, but their results may be of considerable practical value to populations with high need to promote health. With enough varied replications of such trials, meta-analyses may indeed tease out which behaviour change techniques (BCTs) drive successful behaviour change and these robustly identified BCTs then can inform the development of more efficient, briefer interventions, greater understanding of mechanisms of action and, then improved theories.
What is the best theory?
Taking a single theoretical approach to conduct an intervention is no insurance that it is the right approach to the problem, yet in being "theory-driven" such scholars often act as though they have donned the cloak of theoretical invincibility-we should be open to the possibility that a cherished theory does not quite do the job. To advance theory, it is necessary both to identify deficiencies in current models and theories and to provide guidance for future empirical tests (e.g., DiClemente, Crosby, & Kegler, 2009) . For example, the scholars proposing the network-individual-resource model of HIV prevention focused on clear deficits in prominent health promotion models, such as insufficient attention to risk-related resources that individuals or their networks may possess (Johnson, Redding, DiClemente, Dodge, Mustanski et al., 2010, p. S215) . Another problem results when investigators state that an intervention is based on a particular model yet actually follow others (as a careful inspection of their methods may reveal). Similarly, investigators may use elicitation research to shape the themes of the intervention, yet not report how the elicitation research changed the details of intervention content beyond that already planned on the basis of the pre-selected theory. Improved reporting standards and archiving of intervention content would help to rectify this situation over time. Thus, an IPEBA framework should thoroughly consider competing theories and address how future research can produce critical tests between them.
Encouraging theories and tests that can accommodate big science.
No matter how nuanced theories are, all of them make assumptions. Understandably, nearly all assume-tacitly or explicitly-that targeted individuals are living biological organisms subject to environmental conditions. Yet, this assumption can have huge ramifications for the success of trials: When participants complete an intervention, they must live in environments that vary greatly in the extent to which they support the goals of the intervention (Johnson, Redding et al. 2010) . It is quite plausible, therefore, to consider that interventions might fail at longer intervals after the intervention for vulnerable individuals living in difficult environments, such as adolescent minorities who live in communities with high levels of prejudice and discrimination (e.g., Reid, Dovidio, Ballester, & Johnson, in press ). Such factors also directly influence health outcomes for sexual minorities (e.g., Hatzenbuehler, 2009 ). We should consider that trials conducted in developed countries may well operate differently when replicated in developing countries. Thus, an IPEBA framework should be open to the theoretical insights that allied fields such as biology, sociology, and economics might present. Peters et al. (2013) emphasize controlled trials of BCTs-which are a form of efficacy evidence (Flay, 1986 )-but there are other categories that are highly important to public health, especially those providing effectiveness evidence. Ultimately, the theory-related work we do in efficacy trials should lead to better public health outcomes in the community, which is best labelled effectiveness evidence. As Flay argued, the infrastructure supporting controlled trials may be a factor in generating the efficacy results themselves, which complicates replications in community settings. Specifically, controlled trials offer incentives for participation (e.g., monetary sums), trained interventionists, professional settings, participant trackers, and other elements that may be far beyond the resources of community-level interventionists, who may not even be able to evaluate or report measures of the success of their intervention. Thus, if it is difficult to test theories with efficacy data, 1 then try predicting whether the results of these trials will work as well when they are diffused into the community. Similarly, as much as we are aficionados of theories to promote health, we also must recognize that methodological features should be considered. Scholars are more likely to trust evidence that comes from higherquality trials-RCTs and the like -but it is not necessarily the case that lowerquality results would differ. Indeed, some meta-analyses have taken exactly this strategy, trusting the repeated-measures effects that appear in both controlled and uncontrolled trials and de-emphasizing the comparison between intervention and control, recognizing that control groups often receive active intervention content (e.g., Albarracín et al., 2005; de Bruin et al., 2010; Ferrer et al., 2011; Lennon, Huedo-Medina, Gerwien, & Johnson, 2012) . By virtue of including such evidence, meta-analyses can explicitly examine whether the results differ, and they will benefit from a far larger database. As meta-analysts increasingly examine whether methodological quality matters in relation to health promotion success, true gold standards of methodological quality ought to emerge (see Johnson & Low, 2013) . In short, an IPEBA protocol should consider the complexities that community and methodological realities necessitate.
Healthy scepticism about the trappings of controlled trials.
In conclusion, the maze of messy reality for health promotion research presents challenges for the scholarly enterprise and for providing clear public health policy. Nonetheless, despite Peters et al.'s (2013) statement that "a cumulative science of behaviour change can develop" (e.g., p. 1, emphasis added), we assert that one already is developing. Despite all the challenges that Peters et al. and we identify (see also Michie & Johnson, 2013) , regularities in research findings have been documented. Science, like life, is a messy business. To advance science rapidly and efficiently, it is necessary to recognise strengths as well as weaknesses in what has gone before and build on what we have on the ground, whilst keeping an eye on the stars.
